Tilray Inc (Class 2) (TLRY)

$18.20USD

+$18.20 (+1,820.00%)

today (15 min delay)

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

CEO

Brendan Kennedy, MBA

Headquarters

Canada

Employees

688

Revenue (TTM)

136M

Gross Profit

32.55%

Earnings

Cash

$100M

Debt

$437M

TLRY related news

    Popular on Wealthsimple

      Trade app demonstration video

      Commission-free stock trading

      Wealthsimple Trade lets you buy and sell thousands of stocks and exchange-traded funds (ETFs) on major Canadian and U.S. exchanges.

      • Unlimited trades, all commission-free

      • No account minimum means you can get started with as little as $1

      • No jargon, and no paperwork

      • Search and track stocks easily with your watchlist

      • Buy and sell stocks with just a few taps

      Clock

      Start trading in 5 minutes

      1. Download the Wealthsimple Trade mobile app
      2. Securely connect your bank account to deposit funds
      3. Buy and sell stocks with $0 commission fees